Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · DCMSHRIRAM

DCMSHRIRAM

DiversifiedDiversified₹14055 cr market cap
₹888.60 ▲ +1.03% today As of 19 Nov 2026
52-week low ₹874.0052-week high ₹1301.80

-32.4% from the 52-week high · +0.6% above the low

DCM Shriram Ltd. engages in the business of agri-rural, value added, and chlor-vinyl. The company is headquartered in New Delhi, Delhi and currently employs 5,803 full-time employees. The firm's segments include Fertilisers, which manufactures urea; Chloro-Vinyl, which manufactures poly-vinyl chloride, carbide, and chlor alkali products; Shriram Farm solutions, which is engaged in trading of super-phosphate, other fertilizers, seeds and pesticides; Sugar, which manufactures sugar, ethanol and co-generation of power; Bioseed, which produces hybrid seeds, and Others, which includes window systems, cement, rural retail and plaster of paris. Its Agri-Rural Business includes sugar, urea and hybrid seeds, farm inputs merchandising such as, crop care and specialty chemicals. Its Chlor-Vinyl Business includes caustic soda, chlorine, calcium carbide, PVC resins, PVC compounds, power and cement. The company has a value-added business, Fenesta Building Systems, which manufactures unplasticized polyvinyl chloride (UPVC) windows and doors. The company has manufacturing facilities in Rajasthan and Gujarat.

The short version. DCMSHRIRAM reported revenue of ₹4,151 crore for Sep 2026, up 20.9% from a year earlier. Net profit was ₹105 crore (down 33.5% year on year). Return on equity was 11.1% in Mar 2026. Promoter holding was 66.52% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

DCMSHRIRAM trades 32.4% below its 52-week high and 0.6% above its 52-week low.

Change over period: —

1M-12.2%
3M-16.2%
6M-19.9%
1Y-26.1%

2 · The business

Is it growing?

Sales, year on year+20.9%

Sep 2026 revenue of ₹4,151 cr.

Profit, year on year-33.5%

Sep 2026 net profit of ₹105 cr.

Net margin2.5%

2.1 pts lower than a year earlier.

3-year growth-2.1% profit

Revenue compounded at 5.8% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue41513785337340033432345530193519
Net profit105693370212158113179262
Net margin %2.518.311.05.34.63.35.97.4
EPS (₹)6.7244.4723.7213.610.137.2711.4716.81

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue142641274111431120809849830877677771
Net profit8536044479111067674722904
Net margin %6.04.73.97.510.88.19.311.6
EPS (₹)54.7338.7528.6758.4168.4543.2246.3157.99

3 · The quality

How well does it turn capital into profit?

Return on equity was 11.1% in Mar 2026; debt to equity is 0.36.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %11.18.66.914.7
Return on capital %11.211.28.917.9
EBITDA margin %11.611.49.414.1
Net margin %5.94.73.97.5

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR5.8%11.5%
Profit CAGR-2.1%4.8%
Debt to equity0.36
Interest cover6.7x
Current ratio1.49
P/E ratio10.0

4 · The owners

Who holds it, and are they adding?

Promoter holding66.52%

Unchanged over 8 quarters.

Foreign institutions3.98%

Down 0.02 pts over 8 quarters.

Domestic institutions8.32%

Up 0.67 pts over 8 quarters.

Mutual fund schemes15

+3 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter66.5266.5266.5266.5266.5266.5266.5266.520.0
FII4.04.14.133.973.973.973.893.98-0.02
DII7.657.768.058.258.318.568.468.32+0.67
Public21.1120.8120.5220.5320.4920.2420.4420.5-0.61

Mutual fund holdings · Oct 2026

15 schemes hold this stock

12 the month before.

  • UTI Large & Mid Cap Fund1.0% of NAV
  • HDFC BSE India Sector Leaders Index Fund0.9% of NAV
  • UTI BSE India Sector Leaders Exchange Traded Fund0.9% of NAV
  • UTI BSE India Sector Leaders Index Fund0.9% of NAV
  • Bandhan BSE India Sector Leaders Index Fund0.9% of NAV
  • Axis BSE India Sector Leaders Index Fund0.9% of NAV
  • UTI Aggressive Hybrid Fund0.76% of NAV
  • UTI Retirement Fund0.44% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for DCMSHRIRAM are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about DCMSHRIRAM

What is the DCMSHRIRAM share price?

DCMSHRIRAM (DCMSHRIRAM) last closed at ₹888.60, up 1.03% on the day. Its 52-week range is ₹874.00 to ₹1,301.80.

What is the market cap of DCMSHRIRAM?

DCMSHRIRAM has a market capitalisation of about ₹14,055 crore. Its price-to-earnings ratio is 10.0.

How are DCMSHRIRAM's latest results?

DCMSHRIRAM reported revenue of ₹4,151 crore for Sep 2026, up 20.9% from a year earlier. Net profit was ₹105 crore (down 33.5% year on year). Return on equity was 11.1% in Mar 2026. Promoter holding was 66.52% in Sep 2026, up 0.00 points over 8 quarters.

Who owns DCMSHRIRAM?

As of Sep 2026, shareholding was: Promoter 66.52%, FII 3.98%, DII 8.32%, Public 20.5%.

How many mutual funds hold DCMSHRIRAM?

15 mutual fund schemes held DCMSHRIRAM in October 2026. That compares with 12 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 23 Jan 2026 · Interim Dividend - Rs. 3.6
  • 03 Nov 2025 · Interim Dividend - Rs. 3.6
  • 05 Aug 2025 · Final Dividend - Rs. 3.4
  • 24 Jan 2025 · Interim Dividend - Rs. 3.6
  • 11 Nov 2024 · Interim Dividend - Rs. 2
  • 09 Jul 2024 · Final Dividend - Rs. 2.6

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.